These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11054279)

  • 1. Microspheres containing neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 beta protect rats from Staphylococcus aureus-induced peritonitis.
    D'Souza M; Oettinger CW; Milton GV
    J Interferon Cytokine Res; 2000 Oct; 20(10):907-13. PubMed ID: 11054279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting macrophages with microspheres containing cytokine-neutralizing antibodies prevents lethality in gram-negative peritonitis.
    Oettinger CW; D'Souza M; Milton GV
    J Interferon Cytokine Res; 1999 Jan; 19(1):33-40. PubMed ID: 10048766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of microspheres containing cytokine neutralizing antibodies in endotoxemia.
    D'Souza MJ; Oettinger CW; Milton GV
    Drug Dev Ind Pharm; 1999 Jun; 25(6):727-34. PubMed ID: 10349558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493.
    D'Souza MJ; Oettinger CW; Milton GV; Tracey KJ
    J Interferon Cytokine Res; 1999 Oct; 19(10):1125-33. PubMed ID: 10547152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis.
    Uddin MN; Siddiq A; Oettinger CW; D'Souza MJ
    J Drug Target; 2011 Nov; 19(9):752-60. PubMed ID: 21913870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental septic shock with microencapsulated antisense oligomers to NF-kappaB.
    D'Souza MJ; Jin Z; Oettinger CW
    J Interferon Cytokine Res; 2005 Jun; 25(6):311-20. PubMed ID: 15957954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microencapsulation of tumor necrosis factor oligomers: a new approach to proinflammatory cytokine inhibition.
    Oettinger C; D'Souza M
    J Interferon Cytokine Res; 2003 Sep; 23(9):533-43. PubMed ID: 14565862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of murine cardiac allograft survival by microspheres containing TNF alpha and IL1-beta neutralizing antibodies.
    Gerber DA; Oettinger CW; D'Souza M; Milton GV; Larsen CP; Pearson TC
    J Drug Target; 1995; 3(4):311-5. PubMed ID: 8821005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
    J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-alpha production.
    Haziot A; Hijiya N; Schultz K; Zhang F; Gangloff SC; Goyert SM
    J Immunol; 1999 Apr; 162(8):4801-5. PubMed ID: 10202023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
    Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
    J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of TNF-alpha and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus-induced arthritis and the concomitant cartilage destruction in rabbits.
    Kimura M; Matsukawa A; Ohkawara S; Takagi K; Yoshinaga M
    Clin Immunol Immunopathol; 1997 Jan; 82(1):18-25. PubMed ID: 9000038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment.
    Bassetti S; Wasmer S; Hasler P; Vogt T; Nogarth D; Frei R; Widmer AF
    J Rheumatol; 2005 Nov; 32(11):2125-9. PubMed ID: 16265689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of laparoscopy access and antibiotics on the outcome of severe bacterial peritonitis in rats.
    Salgado W; Dos Santos JS; Cunha FQ
    J Laparoendosc Adv Surg Tech A; 2008 Feb; 18(1):5-12. PubMed ID: 18266567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 and TNF-alpha play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess.
    Kielian T; Bearden ED; Baldwin AC; Esen N
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):381-96. PubMed ID: 15099027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
    Karzai W; Cui X; Mehlhorn B; Straube E; Hartung T; Gerstenberger E; Banks SM; Natanson C; Reinhart K; Eichacker PQ
    Anesthesiology; 2003 Jul; 99(1):81-9. PubMed ID: 12826846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination immunotherapy which neutralises the effects of TNF alpha and IL-1 beta attenuates the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat.
    Ruetten H; Thiemermann C
    J Physiol Pharmacol; 1997 Dec; 48(4):605-21. PubMed ID: 9444610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Ioculano M; Calapai G; Zingarelli B; Saitta A; Campo GM; Rizzo A; Caputi AP
    Circ Shock; 1992 Jul; 37(3):236-44. PubMed ID: 1423915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative administration of antibodies against tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) and their impact on peritoneal adhesion formation.
    Kaidi AA; Nazzal M; Gurchumelidze T; Ali MA; Dawe EJ; Silva YJ
    Am Surg; 1995 Jul; 61(7):569-72. PubMed ID: 7793736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.